This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Spi Pharma, Inc.. Active years: 2006-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2020
Title: Innovations by Arun F Amin
Introduction
Arun F Amin is a notable inventor based in Wilmington, DE (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of quick-dissolve solid dosage forms. With a total of 5 patents to his name, his work has the potential to enhance patient compliance and improve medication delivery.
Latest Patents
One of Arun F Amin's latest patents is titled "Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms." This invention comprises a co-processed carbohydrate system and formulations produced from it. These formulations are designed to be directly compressible into solid dosage forms that rapidly and completely dissolve or disintegrate in the oral cavity within 60 seconds. The invention also includes the solid dosage forms produced by directly compressing the co-processed carbohydrate system, ensuring that they dissolve or disintegrate effectively when placed in the oral cavity.
Career Highlights
Arun F Amin is currently associated with Spi Pharma, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on improving the efficiency and effectiveness of drug delivery systems, which is crucial for enhancing patient experiences.
Collaborations
Some of his notable coworkers include Gary Telfer Norman and Kalyan S Nuguru. Their collaborative efforts contribute to the advancement of pharmaceutical technologies and innovations.
Conclusion
Arun F Amin's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving medication delivery systems. His work is poised to make a significant impact on patient care and pharmaceutical practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
